Evidence map›Paper›PMID 38355678›Full record

ArticleScientific reports2024

Explainable hybrid vision transformers and convolutional network for multimodal glioma segmentation in brain MRI.

Ramy A Zeineldin, Mohamed E Karar, Ziad Elshaer, Jan Coburger, Christian R Wirtz, Oliver Burgert, Franziska Mathis-Ullrich

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Personalized Medication for Chronic Diseases Using Multimodal Data-Driven Chain-of-Decisions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ramy A ZeineldinDepartment Artificial Intelligence in Biomedical Engineering (AIBE), Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91052, Erlangen, Germany. ramy.zeineldin@fau.de.
Mohamed E KararFaculty of Electronic Engineering (FEE), Menoufia University, Minuf, 32952, Egypt.
Ziad ElshaerDepartment of Neurosurgery, University of Ulm, 89312, Günzburg, Germany.
Jan CoburgerDepartment of Neurosurgery, University of Ulm, 89312, Günzburg, Germany.
Christian R WirtzDepartment of Neurosurgery, University of Ulm, 89312, Günzburg, Germany.
Oliver BurgertResearch Group Computer Assisted Medicine (CaMed), Reutlingen University, 72762, Reutlingen, Germany.
Franziska Mathis-UllrichDepartment Artificial Intelligence in Biomedical Engineering (AIBE), Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91052, Erlangen, Germany.

Funding

Deutscher Akademischer Austausch Dienst Kairo 91705803
6 · The paper itself

Abstract

Accurate localization of gliomas, the most common malignant primary brain cancer, and its different sub-region from multimodal magnetic resonance imaging (MRI) volumes are highly important for interventional procedures. Recently, deep learning models have been applied widely to assist automatic lesion segmentation tasks for neurosurgical interventions. However, these models are often complex and represented as "black box" models which limit their applicability in clinical practice. This article introduces new hybrid vision Transformers and convolutional neural networks for accurate and robust glioma segmentation in Brain MRI scans. Our proposed method, TransXAI, provides surgeon-understandable heatmaps to make the neural networks transparent. TransXAI employs a post-hoc explanation technique that provides visual interpretation after the brain tumor localization is made without any network architecture modifications or accuracy tradeoffs. Our experimental findings showed that TransXAI achieves competitive performance in extracting both local and global contexts in addition to generating explainable saliency maps to help understand the prediction of the deep network. Further, visualization maps are obtained to realize the flow of information in the internal layers of the encoder-decoder network and understand the contribution of MRI modalities in the final prediction. The explainability process could provide medical professionals with additional information about the tumor segmentation results and therefore aid in understanding how the deep learning model is capable of processing MRI data successfully. Thus, it enables the physicians' trust in such deep learning systems towards applying them clinically. To facilitate TransXAI model development and results reproducibility, we will share the source code and the pre-trained models after acceptance at https://github.com/razeineldin/TransXAI .

Indexed as

Brain NeoplasmsGliomaBrainHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingReproducibility of Results

Identifiers

PMID38355678
PMCPMC10866944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.